A Study of SU11248 In Patients With Metastatic Breast Cancer Who Have Failed Selected Other Therapies.
Assessment of safety and efficacy of SU11248 in patients with metastatic breast cancer who have failed selected other therapies.
Breast Neoplasms
DRUG: SU011248
Anti-tumor efficacy
Tumor control survival safety pharmacokinetics
Assessment of safety and efficacy of SU11248 in patients with metastatic breast cancer who have failed selected other therapies.